27
Participants
Start Date
April 30, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
PF-04634817 Placebo
Oral solution, placebo, single dose
PF-04634817
Oral solution, 1mg, single dose
PF-04634817
Oral solution, 3mg, single dose
PF-04634817
Oral solution, 10mg, single dose
PF-04634817
Oral solution, 30mg, single dose
PF-04634817
Oral solution, 100mg, single dose
PF-04634817
Oral solution, 300mg, single dose
PF-04634817
Oral solution, 600mg, single dose
PF-04634817
Oral solution, 900mg, single dose
PF-04634817
Oral solution, up to 900mg, single dose after food
PF-04634817 Placebo
Oral solution, placebo, single dose after food
Pfizer Investigational Site, New Haven
Lead Sponsor
Pfizer
INDUSTRY